Pyramidal nerve cell loss in Alzheimer's disease

Neurodegeneration

Volumn 5, Issue 4, 1996, Pages 423-427

  Mann, David M A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebral cortex; Dementia; Hippocampus; Pyramidal cells

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CELL LOSS; CELL ORGANELLE; CONFERENCE PAPER; CORRELATION FUNCTION; DISEASE SEVERITY; HIPPOCAMPUS; HUMAN; INTRACELLULAR TRANSPORT; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SENILE PLAQUE;

EID: 0030499743     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0057     Document Type: Conference Paper

References (56)

1. Arriagada PV, Growdon JH, Hedley-White ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639
2. Ball MJ (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol 37:111-118
3. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:1-20
4. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Brit J Psychiat 114:797-811
5. Braak H, Braak E (1986) Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. In: Swaab DF, Fliers E, Mirmiran M, Van Gool WA, Van Haaren F. Progress in Brain Research. Vol. 70. Elsevier Science Publishers BV (Biomedical Division), 185-212
6. Brun A, Liu X, Erikson C (1995) Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration 4:171-177
7. Colon EJ (1973) The cerebral cortex in presenile dementia. A quantitative analysis. Acta Neuropathol 23:281-290
8. Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry G (1995) Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol 89:291-295
9. Davies CA, Mann DMA, Sumpter PQ, Yates P (1987) A quantitative analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78:151-164
10. Davies DC, Horwood N, Isaacs SL, Mann DMA (1992) The effect of age and Alzheimer's disease in pyramidal neurone density in the individual fields of the hippocampal formation. Acta Neuropathol 83:510-517
11. Dayan AD, Ball MJ (1973) Histometric observations on the metabolism of tangle-bearing neurons. J Neurol Sci 19:433-436
12. DeKosky ST, Sheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27:457-564
13. De La Monte S (1989) Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25:450-459.
14. Doebler JA, Markesbery WR, Anthony A, Rhoads RE (1987) Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease. J Neuropathol Exp Neurol 46:28-39
15. Francis PT, Webster M-T, Procter AW, Clarke NA, Holmes C, Bowen D, Doshi B, Mann DMA, Snowden J, Neary D (1993) Soluble β-amyloid precursor protein and pyramidal neurone loss are not diagnostic of Alzheimer's disease. Lancet 341, 431
16. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L, Younkin LH, Suzuki N, Younkin SG (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. J Biol Chem 270:7013-7016
17. Hamos JE, DeGennaro LJ, Drachman DA (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-361
18. Hamos JE, Oblas B, Pulaski-Salo D, Welch WJ, Bole DG, Drachman DA (1991) Expression of heat shock proteins in Alzheimer's disease. Neurology 41:345-350
19. Hansen LA, Teresa R, Davies P, Terry RD (1988) Neocortical morphometry, lesion count and choline acetyl transferase levels in the age spectrum of Alzheimer's disease. Neurology 38:48-54
20. Heinonen O, Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Sorvari H, Kosunen O, Paljarvi L, Ryynanen M, Riekkinen PJ (1995) Alzheimer pathology of patients carrying apolipoprotein E E4 allele. Neurobiol Aging 16:505-513
21. Honer WG, Dickson DW, Gleeson J, Davies P (1992) Regional synaptic pathology in Alzheimer's pathology. Neurobiol Aging 13:375-382
22. Hubbard BM, Anderson JM (1981) A quantitative study of cerebral atrophy in old age and senile dementia. J Neurol Sci 50:135-145
23. Hubbard BM, Anderson JM (1985) Age-related variations in the neurone content of the cerebral cortex in senile dementia of Alzheimer type. Neuropath Appl Neurobiol 11:369-382
24. Hyman BT, Marzloff K, Arriagada PV (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 52:594-600
25. Lippa CF, Hamos JE, Pulaski-Salo D, Degennaro LJ, Drachman DA (1992) Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses. Neurobiol Aging 13:405-411
26. Mann DMA, Yates PO (1981) The relationship between formation of senile plaques and neurofibrillary tangles and changes in nerve cell metabolism in Alzheimer-type dementia. Mech Ageing Dev 17:395-401
27. Mann DMA, Neary D, Yates PO, Lincoln J, Snowden JS, Stanworth P (1981a) Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease. Neuropath Appl Neurobiol 7:37-47
28. Mann DMA, Neary D, Yates PO, Lincoln J, Snowden JS, Stanworth P (1981b) Alterations in protein synthetic capability innerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry 44:97-102
29. Mann DMA, Yates PO, Marcyniuk B (1985) Some morphometric observation on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer-type and Down's syndrome in middle age. J Neurol Sci 69:139-159
30. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS (1988) The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropath Appl Neurobiol 14:177-195
31. Mann DMA, Yates PO, Marcyniuk B, Ravindra CR (1987) Loss of nerve cells from cortical and subcortical areas in Down's syndrome patients at middle age: quantitative comparisons with younger Down's patients and patients with Alzheimer's disease. J Neurol Sci 80:79-89
32. Mann DMA, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type:neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56:605-614
33. Masliah E, Hansen T, Mallory M, Terry RD (1991) Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol 81:428-433
34. McKee AC, Kosik KS, Kowall NW (1991) Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 30:156-165
35. Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4:1-11
36. Najlerahim A, Bowen DM (1989) Regional weight loss in the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type. Acta Neuropathol 75:509-512
37. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Benton JS, Northen B, Yates PO, Davison AN (1986) Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 49:163-174
38. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN (1986) Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 49:229-237
39. Regeur L, Jensen BJ, Pakkenberg H, Evans SM, Pakkenberg B (1994) No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging 15:347-352
40. Renkawek K, Basman GJCGM, de Jong WW (1994) Expression of small heat-shock protein hsp27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol 87:511-519
41. Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol 33:190-199
42. Scheff SW, DeKosky ST, Price DA (1990) A quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11:29-37
43. Shefer VF (1973) Absolute numbers of neurones and thickness of the cerebral cortex during ageing, senile and vascular dementia, and Pick's and Alzheimer's diseases. Neurosci Behav Physiol 6:319-324
44. Shefer VF (1977) Hippocampal pathology as a possible factor in the pathogenesis of senile dementias. Neurosci Behav Physiol 8:236-239
45. Smith MA, Taneda S, Richey PL, Miyata S, Van S-D, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci (USA) 91:5710-5714
46. Smith MA, Kutty RK, Richey PL, Van S-D, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme Oxygenase-1 associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145:42-47
47. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64:2660-2666
48. Smith MA, Richey PL, Kutty RK, Wiggert B, Perry G (1995) Ultrastructural localization of Heme Oxygenase-1 to the neurofibrillary pathology of Alzheimer disease. Molec Chem Neuropathol 24:227-230
49. Sumpter PQ, Mann DMA, Davies CA, Yates PO, Snowden JS, Neary D (1986) An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal cells of the cerebral cortex in Alzheimer's disease. Neuropath Appl Neurobiol 12:305-319
50. Terry RD, De Teresa R, Hansen LA (1987) Neocortical cell counts in normal human adult ageing. Ann Neurol 21:530-539
51. Terry RD, Masliah E, Salmon P, Butters N, De Teresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
52. Tomlinson BE, Henderson G (1976) Some quantitative cerebral findings in normal and demented old people. In Terry RD, Gerhon S (eds) Neurobiology of Aging. Raven Press, New York, 183-204
53. Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia. J Neurol Sci 56:343-356
54. Yan S-D, Chen X, Schmidt A-M, Brett J, Godman G, Zou Y-S, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen S-H, Stern D (1994) Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc Natl Acad Sci 91:7787-7791
55. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Medicine 1:693-699
56. Zhan S-S, Beyreuther K, Schmitt HP (1993) Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 4:66-74